Gentically Modified Animals & Respiratory Diseases
The objective of this Project Licence is to identify or evaluate biological processes involved in the development or disease progression of asthma (which affects 53 million patients worldwide) or chronic obstructive pulmonary disease (the sixth most common cause of death worldwide) that might lead to new medicines for these diseases.
Date: Wed Nov 30 16:02:53 GMT 2005
